Skip to content

Author

Peng Chen

We have 4 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Third-generation EGFR-TKI plus pemetrexed-platinum chemotherapy versus TKI monotherapy as first-line treatment for EGFR-mutant lung adenocarcinoma with brain parenchymal metastases

Objective To evaluate the efficacy and safety of first-line third-generation EGFR-tyrosine kinase inhibitor (EGFR-TKI) combined with pemetrexed-platinum chemotherapy in patients with EGFR-mutant advanced lung adenocarcinoma and brain parenchymal metastases. Methods A bicenter retrospective cohort study was conducted. A...

Jian-Xi Zhou, Ying-Hao Wang, Kang Wen et al. · 0 citations
Open access Sep 2026

Ivonescimab Plus Chemotherapy versus Bevacizumab Plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma After EGFR-TKI Failure: A Two-Center Retrospective Real-World Propensity Score-Matched Study

Objective To evaluate the efficacy and safety of ivonescimab plus chemotherapy versus bevacizumab plus chemotherapy in advanced EGFR-mutant lung adenocarcinoma after EGFR-TKI failure, and provide the first real-world head-to-head comparative evidence. Methods This two-center retrospective propensity score-matched (PSM)...

Jian-Xi Zhou, Ying-Hao Wang, Kang Wen et al. · 0 citations
Open access Aug 2026

XPO1-mediated TRIM21 nuclear export reprograms TREM2+ macrophage polarization by targeting IRF3 to augment anti-PD-1 efficacy in small cell lung cancer

An XPO1-TRIM21-TNFSF15 axis is defined that promotes the polarization of immunosuppressive TREM2+ macrophages, which ultimately orchestrates immune exclusion by impairing antigen presentation and enhances the efficacy of anti-PD1 immunotherapy in mice.

Qing-Wu Du, Ting-Ting Qin, Jing-Ya Wang et al. · 0 citations
Sep 2026

TWF1 inhibition overcomes cisplatin resistance in NSCLC by inducing ferroptosis via p53-dependent SLC7A11 repression and autophagy-mediated glutathione metabolism reprogramming

TTF1 is identified as a critical regulator of cisplatin resistance and ferroptosis, highlighting the therapeutic potential of TWF1 inhibition combined with cisplatin to overcome chemoresistance, possibly providing new strategies for improving NSCLC treatment outcomes.

Meng-Wei Zhang, Yu Wang, Si-Yi Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.